Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 25 01 2019
accepted: 29 04 2019
entrez: 4 6 2019
pubmed: 4 6 2019
medline: 10 9 2020
Statut: epublish

Résumé

Chemokine receptor CXCR4, its ligand stromal cell-derived factor-1 (CXCL12) and the decoy receptor atypical chemokine receptor 3 (ACKR3, also named CXCR7), are involved in the guidance of migrating cells in different anatomical districts. Here, we investigated the role of the

Identifiants

pubmed: 31156639
doi: 10.3389/fimmu.2019.01092
pmc: PMC6529557
doi:

Substances chimiques

ACKR3 protein, human 0
CXCL12 protein, human 0
Chemokine CXCL12 0
Receptors, CXCR 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1092

Références

Am J Pathol. 1999 Apr;154(4):1125-35
pubmed: 10233851
Nat Genet. 2000 Oct;26(2):216-20
pubmed: 11017081
Yeast. 2000 Dec;17(4):294-301
pubmed: 11119306
Dev Cell. 2002 Jul;3(1):127-36
pubmed: 12110173
Cell. 2002 Nov 27;111(5):647-59
pubmed: 12464177
Nature. 2003 Jan 16;421(6920):279-82
pubmed: 12508118
Development. 2003 Nov;130(21):5281-90
pubmed: 12954720
Methods Mol Med. 2005;105:171-98
pubmed: 15492396
BMC Dev Biol. 2007 Mar 29;7:23
pubmed: 17394634
BMC Dev Biol. 2007 May 22;7:54
pubmed: 17517144
Development. 2007 Jul;134(13):2459-68
pubmed: 17537794
Curr Biol. 2007 Jun 19;17(12):1026-31
pubmed: 17570670
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15735-40
pubmed: 17898181
Cell. 2008 Feb 8;132(3):463-73
pubmed: 18267076
J Neuroimmunol. 2008 Jul 31;198(1-2):9-13
pubmed: 18533280
J Am Soc Nephrol. 2009 Aug;20(8):1714-23
pubmed: 19443644
Genes Dev. 2009 Oct 1;23(19):2272-7
pubmed: 19797767
Development. 2009 Dec;136(23):4001-9
pubmed: 19906867
Blood. 2010 Jun 17;115(24):5102-10
pubmed: 20154215
Dev Dyn. 2010 Oct;239(10):2761-8
pubmed: 21038448
Neuron. 2011 Jan 13;69(1):77-90
pubmed: 21220100
Development. 2011 May;138(9):1717-26
pubmed: 21429983
BMC Cell Biol. 2011 May 18;12:21
pubmed: 21592329
Blood. 2012 Jan 12;119(2):465-8
pubmed: 22110250
Dev Cell. 2012 Apr 17;22(4):824-36
pubmed: 22516200
Development. 2012 Jun;139(12):2246-53
pubmed: 22619392
Curr Biol. 2012 Oct 9;22(19):1789-94
pubmed: 22921365
J Cell Biol. 2013 Feb 4;200(3):337-55
pubmed: 23382464
PLoS One. 2013 May 20;8(5):e64058
pubmed: 23700457
Development. 2013 Oct;140(19):4031-40
pubmed: 24046319
Immunology. 2014 Jan;141(1):111-22
pubmed: 24116850
Cell. 2013 Oct 24;155(3):674-87
pubmed: 24119842
Nat Immunol. 2014 Jul;15(7):623-30
pubmed: 24813163
Microvasc Res. 2014 Nov;96:23-30
pubmed: 24928500
Acta Biochim Biophys Sin (Shanghai). 2014 Aug;46(8):641-6
pubmed: 25001479
Nature. 2014 Aug 21;512(7514):314-8
pubmed: 25119043
Elife. 2015 Apr 15;4:null
pubmed: 25875301
Int J Cancer. 2015 Dec 15;137(12):2825-36
pubmed: 26100110
Sci Rep. 2017 Aug 15;7(1):8289
pubmed: 28811579
J Genet Genomics. 2017 Oct 20;44(10):483-492
pubmed: 29037991
F1000Res. 2018 Jan 23;7:95
pubmed: 29416853
Cell Rep. 2019 Feb 5;26(6):1473-1488.e9
pubmed: 30726732
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Nature. 1996 Aug 15;382(6592):635-8
pubmed: 8757135
Biochem Biophys Res Commun. 1998 Jan 6;242(1):46-53
pubmed: 9439607
Nature. 1998 Jun 11;393(6685):591-4
pubmed: 9634237

Auteurs

Chiara Tobia (C)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Paola Chiodelli (P)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Andrea Barbieri (A)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Simone Buraschi (S)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Elena Ferrari (E)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Stefania Mitola (S)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Giuseppe Borsani (G)

Unit of Biology and Genetics, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Jessica Guerra (J)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Marco Presta (M)

Unit of Experimental Oncology and Immunology, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH